NIP
IONS icon

Nicholas Investment Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Nicholas Investment Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,186
Closed -$1.66M – 218
2024
Q1 		$1.66M Buy
38,186
+7,741
+25% +$369K 0.17% 160
2023
Q4 		$1.54M Buy
+30,445
New +$1.46M 0.18% 148
2013
Q3 		– Sell
-44,195
Closed -$1.19M – 307
2013
Q2 		$1.19M Buy
+44,195
New +$940K 0.11% 262

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nicholas Investment Partners's IONS Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 38,186 shares — an estimated $1.66M sold.

Nicholas Investment Partners first reported a position in IONS in Q2 2013 and held it in 3 quarters. The position peaked at $1.66M in Q1 2024. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 38,186 Ionis Pharmaceuticals shares in Q2 2024, an estimated $1.66M.
  • Nicholas Investment Partners first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Nicholas Investment Partners's Ionis Pharmaceuticals position peaked at $1.66M in Q1 2024.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.